ClinicalTrials.Veeva

Menu

COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Inherited Retinal Disease (COCO-IRD)

University of Wisconsin (UW) logo

University of Wisconsin (UW)

Status

Enrolling

Conditions

Retinal Disease

Treatments

Device: Optos imaging
Device: Clarus imaging
Device: Spectralis FAF imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT06380075
Protocol Version 3/22/24 (Other Identifier)
2024-0480
SMPH/OPHTHAL&VIS SCI/GEN (Other Identifier)
A536000 (Other Identifier)

Details and patient eligibility

About

The goal of this research study is to compare two ultrawide field cameras to the gold standard imaging system to evaluate the back of the eye. The main question it aims to answer is the same results and information can be acquired from all of the cameras for evaluating and monitoring inherited retinal diseases (IRDs).

Participants will:

  • undergo pupillary dilation
  • have photographs taken of the inside of the eyes using three different cameras

Enrollment

50 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants 18 years and older with a clinical and/ or genetic diagnosis of IRD recruited either from the clinic and/or the Inherited Ocular Disease Registry to participate in this trial
  • Participants that are willing to participate as evidenced by signing the written informed consent

Exclusion criteria

  • Presence of ocular conditions other than an IRD which may affect the quality of ocular imaging including but not limited to advanced cataracts, corneal disorders, nystagmus, vitreous hemorrhage, or poor dilation
  • Presence of ocular conditions other than an IRD which may affect interpretation of retinal imagining including but not limited to epiretinal membrane, choroidal neovascular membrane, or macular scarring
  • Patients with advanced IRDs who are unable to fixate for imaging
  • Patients unable to tolerate ocular imaging
  • Patients who do not wish to participate

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Fundus autofluorescence (FAF) imaging
Experimental group
Treatment:
Device: Spectralis FAF imaging
Device: Clarus imaging
Device: Optos imaging

Trial contacts and locations

1

Loading...

Central trial contact

Angie Adler

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems